OCLAIZ
OCLAIZ
RegistradaNominativa · Brasil
Outros setores
Andamento no INPI
- Depósito27/04/22
- Publicação10/01/23
- Exame
- Deferimento16/05/23
- Concessão26/12/23
- Vigente27/04/32
Registro concedido em 26/12/2023 e em vigor até 27/04/2032, quando precisa ser renovado.
Proteção válida até:27/04/2032
Vigiar esta marcaÚltima movimentação publicada pelo INPI: 09/04/2024 (RPI 2779). Atualizamos a cada nova RPI, publicada semanalmente.
Marca registrada: vale avaliar o risco de conflito
A marca "OCLAIZ" está registrada no Brasil. Se você usa ou pretende usar um nome similar, pode haver risco de conflito. Vale olhar classes, histórico e despachos antes de decidir o próximo passo.
Panorama da marca
- Situação INPI
- Registro de marca em vigor (Madri)
- Tramitação até registro
- 1 ano e 8 meses
- Eventos no processo
- 4
- Última atualização
- 09 de abril de 2024
Dados do processo
- Titular
- Camurus AB
- Procurador
- Licks AdvogadosVer perfil do escritório
- Número do processo
- 501672836
- Número de registro
- 501672836
- Natureza
- Madri Produto/Serviço
- Data do depósito
- 27 de abril de 2022
- Data do registro
- 26 de dezembro de 2023
- Válido até
- 27 de abril de 2032
Produtos e serviços cobertos
Pharmaceutical preparationspharmaceutical preparations for injectionpharmaceutical preparation for subcutaneous injectionpharmaceutical preparations for the treatment of endocrine diseases and disorderspharmaceutical preparations for the treatment of tumourspharmaceutical preparations for the treatment of carcinoid tumourspharmaceutical preparations comprising peptides for hormonal treatment and tumour treatmentpharmaceutical preparations for the treatment of neuroendocrine tumourspharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumourspharmaceutical preparations for the treatment of gastrointestinal diseases and disorderspharmaceutical preparations for gastrointestinal bleeding disorderspharmaceutical preparations for the treatment of gastrointestinal bleeding disorderspharmaceutical preparations for the treatment of esophageal bleedingpharmaceutical preparations for metabolic disorderspharmaceutical preparations for the treatment of acromegalypharmaceutical preparations for the treatment of polycystic liver diseasepharmaceutical preparations for the treatment of respiratory diseases or syndromepharmaceutical preparations for the treatment of respiratory distress syndromepharmaceutical preparations for the treatment of acute respiratory distress syndromepharmaceutical preparations for the treatment of disorders of the autonomic nervous systempharmaceutical preparations intended to block growth hormone
Devices for administration of pharmaceuticals for the treatment of endocrine diseases and disordersdevices for administration of pharmaceuticals for the treatment of tumoursdevices for administration of pharmaceuticals for the treatment of carcinoid tumoursdevices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatmentdevices for administration of pharmaceuticals for the treatment of neuroendocrine tumoursdevices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumoursdevices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disordersdevices for administration of pharmaceuticals for gastrointestinal bleeding disordersdevices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disordersdevices for administration of pharmaceuticals for the treatment of esophageal bleedingdevices for administration of pharmaceuticals for metabolic disordersdevices for administration of pharmaceuticals for the treatment of acromegalydevices for administration of pharmaceuticals for the treatment of polycystic liver diseasedevices for administration of pharmaceuticals for the treatment of respiratory diseases or syndromedevices for administration of pharmaceuticals for the treatment of respiratory distress syndromedevices for administration of pharmaceuticals for the treatment of acute respiratory distress syndromedevices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous systemdevices for administration of pharmaceuticals intended to block growth hormonesyringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorderssyringes for administration of pharmaceuticals for the treatment of tumourssyringes for administration of pharmaceuticals for the treatment of carcinoid tumourssyringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatmentsyringes for administration of pharmaceuticals for the treatment of neuroendocrine tumourssyringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumourssyringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorderssyringes for administration of pharmaceuticals for gastrointestinal bleeding disorderssyringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorderssyringes for administration of pharmaceuticals for the treatment of esophageal bleedingsyringes for administration of pharmaceuticals for metabolic disorderssyringes for administration of pharmaceuticals for the treatment of acromegalysyringes for administration of pharmaceuticals for the treatment of polycystic liver diseasesyringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndromesyringes for administration of pharmaceuticals for the treatment of respiratory distress syndromesyringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndromesyringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous systemsyringes for administration of pharmaceuticals intended to block growth hormonepens for administration of pharmaceuticals for the treatment of endocrine diseases and disorderspens for administration of pharmaceuticals for the treatment of tumourspens for administration of pharmaceuticals for the treatment of carcinoid tumourspens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatmentpens for administration of pharmaceuticals for the treatment of neuroendocrine tumourspens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumourspens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorderspens for administration of pharmaceuticals for gastrointestinal bleeding disorderspens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorderspens for administration of pharmaceuticals for the treatment of esophageal bleedingpens for administration of pharmaceuticals for metabolic disorderspens for administration of pharmaceuticals for the treatment of acromegalypens for administration of pharmaceuticals for the treatment of polycystic liver diseasepens for administration of pharmaceuticals for the treatment of respiratory diseases or syndromepens for administration of pharmaceuticals for the treatment of respiratory distress syndromepens for administration of pharmaceuticals for the treatment of acute respiratory distress syndromepens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous systempens for administration of pharmaceuticals intended to block growth hormonedevices for subcutaneous administration of pharmaceuticalsdevices for parenteral administration of pharmaceuticalsdevices for injection of pharmaceutical depotsdevices for subcutaneous injection of pharmaceutical depotdevices for parenteral injection of pharmaceutical depotdevices for injection of injection fluidsdevices for injection of injection depotsyringes for subcutaneous administration of pharmaceuticalssyringes for parenteral administration of pharmaceuticalssyringes for injection of pharmaceutical depotssyringes for subcutaneous injection of pharmaceutical depotsyringes for parenteral injection of pharmaceutical depotsyringes for injection of injection fluidssyringes for injection of injection depotsyringes for injectionssyringes for medical usespens for subcutaneous administration of pharmaceuticalspens for parenteral administration of pharmaceuticalspens for injection of pharmaceutical depotspens for subcutaneous injection of pharmaceutical depotpens for parenteral injection of pharmaceutical depotpens for injection of injection fluidspens for injection of injection depotpens for injectionspens for medical uses
Linha do tempo do processo
4 eventosMovimentações mais recentes da marca “OCLAIZ” publicadas na Revista da Propriedade Industrial (RPI). O detalhe de cada despacho fica na consulta completa.
- Concessão / deferimento26 de dez. de 2023RPI 2764
Concessão de registro em designação
Detalhes na consulta completa
Saiba mais (+1 movimentação)
Veja o histórico completo de despachos desta marca e receba alertas de novas movimentações.
Ver histórico completoO que fazer se a sua marca se aproxima de "OCLAIZ"?
Conflitos de marcas no Brasil são resolvidos com base na anterioridade do depósito, nas classes de Nice e no segmento de atuação. O processo tem várias fases e pode ficar complexo quando o nome é parecido ou o mercado se cruza. Uma leitura cuidadosa ajuda a decidir se vale seguir, ajustar ou recuar.
A TrademarkIQ cruza histórico, decisões e padrões de aprovação por classe e setor em uma base com +6 milhões de processos brasileiros. Isso ajuda a enxergar o risco com mais contexto e a encontrar o melhor caminho comercial e jurídico para a sua marca.
Outras marcas do titular
Processos de marca no INPI em nome de Camurus Ab.
Escritórios especializados
B
Brasville
75% aprovação
Pinc Registro de Marca
88% aprovação
Di Blasi, Parente & Advogados Associados
90% aprovação
Quer registrar a sua marca?
- 1Diga o nome e o ramo. A análise de anterioridade sai da base oficial do INPI, a mesma que você acabou de consultar.
- 2Um escritório verificado assume o caso, define as classes e a especificação, e protocola no INPI.
- 3Você recebe o número do processo e acompanha cada despacho até a decisão final.
Sem custo para pedir a análise. O preço depende do escritório e do caso.
Dados atualizados a partir de uma base com +6 milhões de marcas brasileiras analisadas. Esta página é informativa e não substitui parecer jurídico, mas ajuda a orientar a decisão com mais contexto comercial e técnico.